Cubist Systematic Strategies’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-96,268
Closed -$2.06M 2922
2024
Q4
$2.06M Sell
96,268
-240,380
-71% -$5.85M 0.01% 1328
2024
Q3
$10.5M Buy
+336,648
New +$8.38M 0.06% 429
2024
Q2
Sell
-273,849
Closed -$2.9M 3082
2024
Q1
$2.9M Buy
273,849
+56,646
+26% +$567K 0.02% 1356
2023
Q4
$2.61M Buy
217,203
+37,154
+21% +$304K 0.02% 1320
2023
Q3
$1.26M Sell
180,049
-20,601
-10% -$190K 0.01% 1709
2023
Q2
$1.71M Sell
200,650
-150,260
-43% -$1.25M 0.01% 1605
2023
Q1
$3.21M Buy
350,910
+181,354
+107% +$2.32M 0.02% 1289
2022
Q4
$1.93M Sell
169,556
-66,628
-28% -$987K 0.01% 1886
2022
Q3
$4.02M Buy
236,184
+68,236
+41% +$1.46M 0.02% 1291
2022
Q2
$3.61M Buy
167,948
+110,973
+195% +$3.08M 0.02% 1291
2022
Q1
$2.11M Buy
56,975
+42,812
+302% +$1.67M 0.02% 1424
2021
Q4
$644K Sell
14,163
-25,737
-65% -$1.34M 0.01% 2257
2021
Q3
$2.53M Buy
39,900
+34,581
+650% +$2.63M 0.03% 857
2021
Q2
$487K Sell
5,319
-51,119
-91% -$4.06M 0.01% 2031
2021
Q1
$3.84M Sell
56,438
-18,778
-25% -$1.46M 0.05% 586
2020
Q4
$5.45M Buy
75,216
+26,390
+54% +$1.53M 0.07% 406
2020
Q3
$1.85M Buy
48,826
+36,811
+306% +$1.24M 0.03% 953
2020
Q2
$426K Buy
+12,015
New +$342K 0.01% 1670
2020
Q1
Sell
-34,951
Closed -$754K 2193
2019
Q4
$754K Buy
34,951
+28,989
+486% +$665K 0.01% 1331
2019
Q3
$135K Sell
5,962
-11,575
-66% -$321K ﹤0.01% 1879
2019
Q2
$631K Sell
17,537
-29,788
-63% -$953K 0.01% 1326
2019
Q1
$1.49M Buy
47,325
+20,278
+75% +$591K 0.05% 566
2018
Q4
$680K Buy
27,047
+17,911
+196% +$460K 0.03% 769
2018
Q3
$264K Buy
+9,136
New +$171K 0.01% 1257

Other funds holding CDNA

Cubist Systematic Strategies's CDNA Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of CareDx (CDNA) in Q1 2025, closing a stake of 96,268 shares — an estimated $2.06M sold.

Cubist Systematic Strategies first reported a position in CDNA in Q3 2018 and held it in 24 quarters. The position peaked at $10.5M in Q3 2024. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 96,268 CareDx shares in Q1 2025, an estimated $2.06M.
  • Cubist Systematic Strategies first reported a position in CareDx in Q3 2018 and held it in 24 quarters.
  • Cubist Systematic Strategies's CareDx position peaked at $10.5M in Q3 2024.
  • 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.